BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.35 -4.26%
Financial Fact:
Interest expense: -21.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Interest expense: -21.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $171.16 million versus the consensus estimate of $160.8 million.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
- AI chip sell-off is ‘unmoored from fundamentals,’ LYNX says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
